📰 Given Fortrea News
Given Fortrea News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Fortrea. Real-time updates on events, politics, business and more.
June 6, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Fortrea to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Analyst Recommendations This is a […]
May 29, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare Fortrea to similar companies based on the strength of its earnings, institutional ownership, dividends, profitability, valuation, analyst recommendations and risk. Insider & Institutional Ownership 47.5% of shares […]
May 27, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it compare to its competitors? We will compare Fortrea to similar businesses based on the strength of its earnings, dividends, institutional ownership, risk, valuation, profitability and analyst recommendations. Profitability This table compares Fortrea and its […]
May 27, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Fortrea to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a […]
May 27, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its rivals? We will compare Fortrea to similar businesses based on the strength of its dividends, analyst recommendations, risk, institutional ownership, profitability, valuation and earnings. Analyst Recommendations This is a […]
May 26, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 44 public companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare Fortrea to related companies based on the strength of its analyst recommendations, profitability, institutional ownership, dividends, earnings, risk and valuation. Profitability This table compares Fortrea and its […]
May 26, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 44 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its rivals? We will compare Fortrea to similar companies based on the strength of its earnings, dividends, risk, valuation, analyst recommendations, profitability and institutional ownership. Analyst Recommendations This is a […]
May 21, 2024
Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Profitability This table compares Elekta AB (publ) […]
May 20, 2024
Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 public companies in the “Medical laboratories” industry, but how does it contrast to its competitors? We will compare Fortrea to similar companies based on the strength of its valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Valuation and Earnings This table compares Fortrea […]
April 28, 2024
Vyant Bio (OTCMKTS:VYNT – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends. Profitability This table compares Vyant Bio and Fortrea’s net […]